could catalyze the formal [2 þ 2]-cycloaddition of acyl
chlorides (precursors to monosubstituted ketenes) with
imino esters to give β-lactams with excellent enantioselec-
tivity and good diastereoselectivity favoring the cis-
isomer.6 Shortly afterward Fu’s group reported that an
azaferrocene possessing planar chirality could catalyze the
Staudinger reaction of N-tosyl imines with disubstituted
ketenes (ketoketenes) with high enantioselectivity and
good diastereoselectivity favoring the cis-isomer.7 Ye and
Smith also showed that chiral NHC catalysts could cata-
lyze the Staudinger reaction of N-Boc and N-tosyl aryli-
mines with ketoketenes, again favoring formation of the
cis-diastereomer.8
While most of these methods have shown a preference
for formation of the cis-diastereomer, Fu’s group showed
that, under chiral azaferrocene catalytic conditions, the use
of N-triflyl arylimines as coupling partners caused an
interesting change in diastereoselectivity to favor the
trans-diastereomer.9 Fu’s group proposed that the nucleo-
philic catalyst added first to the highly electrophilic imine
to give a zwitterionic species A (Scheme 1). Intermediate A
would then add to the ketoketene before 4-exo-tet cycliza-
tion would give the trans-β-lactam and regenerate the
catalyst.9 Lectka’s group also reported an anionic 2-aryl-
2-imidazoline nucleophilic catalytic system that catalyzed
formation of trans-β-lactams from imino esters with good
to excellent diastereoselectivity.11
which are prepared from the expensive trifluoromethane-
sulfonamide (ca. $500/10 g).12 Moreover, Fu’s system
works best with alkylarylketenes and diphenylketene as
ketene substrates. We considered that the use of N-tosyl
arylimines as starting materials might provide a more
practical approach to trans-β-lactams because of the in-
expensiveness of the p-toluenesulfonamide precursor (ca.
$1/10 g).12 We reasoned that the use of a chiral phosphine
catalyst would favor formation of adduct A (rather than B)
even when a less electrophilic imine such as an N-tosyl
imine was used (Scheme 2). This would be expected due to
the superior nucleophilicity of the phosphine catalyst
relative to amine catalysts.13 Our approach would thus
allow trans-β-lactams to be accessed from inexpensive
N-tosyl arylimines.
Scheme 2. Phosphine-Catalyzed Synthesis of trans-β-Lactams
Scheme 1. Fu’s Proposed Mechanisms for trans-β-Lactam and
cis-β-Lactam Formation
Our studies began with the optimization of the phos-
phine-catalyzed reaction of ethylphenylketene 1a with
various N-tosyl arylimines 2 (Table 1). As with our pre-
vious studies on β-lactone forming reactions, BINA-
PHANE was found to be the optimal catalyst with
respect to diastereoselectivity and enantioselectivity, albeit
modest (entry 3).14 A more satisfactory level of enantio-
selectivity (up to 60% ee) was observed after electronic
tuning of the aryl ring of the imine (entry 6). In this case an
electron-donating substituent (4-MeO) on the aryl imine
led to optimal enantioselectivity. It was found necessary to
add a solution of the ketene using a syringe pump to the
A disadvantage of Fu’s elegant asymmetric synthesis of
trans-β-lactams is that it relies on the use of N-triflyl imines
(6) (a) Taggi, A. E.; Hafez, A. M.; Wack, H.; Young, B.; Drury, W. J.,
III; Lectka, T. J. Am. Chem. Soc. 2000, 122, 7831–7832. (b) Taggi, A. E.;
Hafez, A. M.; Wack, H.; Young, B.; Ferraris, D.; Lectka, T. J. Am.
Chem. Soc. 2002, 124, 6626–6635. (c) France, S.; Wack, H.; Hafez,
A. M.; Taggi, A. E.; Witsil, D. R.; Lectka, T. Org. Lett. 2002, 4, 1603–
1605. (d) France, S.; Shah, M. H.; Weatherwax, A.; Wack, H.; Roth,
J. P.; Lectka, T. J. Am. Chem. Soc. 2005, 127, 1206–1215.
(7) Hodous, B. L.; Fu, G. C. J. Am. Chem. Soc. 2002, 124, 1578–1579.
(8) (a) Zhang, Y.-R.; He, L.; Wu, X.; Shao, P.-L.; Ye, S. Org. Lett.
2008, 10, 277–280. (b) Duguet, N.; Campbell, C. D.; Slawin, A. M. Z.;
Smith, A. D. Org. Biomol. Chem. 2008, 6, 1108–1113.
(12) From Aldrich catalog (www.sigmaaldrich.com): p-toluenesulfo-
namide (98%): $24 for 250 g; trifluoromethanesulfonamide (95%):
$264.50 for 5 g.
(9) Lee, E. C.; Hodous, B. L.; Bergin, E.; Shih, C.; Fu, G. C. J. Am.
Chem. Soc. 2005, 127, 11586–11587.
(13) (a) Pearson, R. G.; Songstad, J. J. Am. Chem. Soc. 1967, 89,
1827–1836. (b) Methot, J. L.; Roush, W. R. Adv. Synth. Catal. 2004, 346,
1035–1050. (c) Wei, Y.; Sastry, G. N.; Zipse, H. J. Am. Chem. Soc. 2008,
130, 3473–3477.
(14) (a) Mondal, M.; Ibrahim, A. A.; Wheeler, K. A.; Kerrigan, N. J.
Org. Lett. 2010, 12, 1664–1667. (b) Ibrahim, A. A.; Wei, P.-H.; Harzmann,
G. D.; Kerrigan, N. J. J. Org. Chem. 2010, 75, 7901–7904. (c) Ibrahim,
A. A.; Harzmann, G. D.; Kerrigan, N. J. J. Org. Chem. 2009, 74, 1777–
1780.
(10) Huang, Y.; Calter, M. A. Tetrahedron Lett. 2007, 48, 1657–1659.
(11) Nonenantioselective approaches to trans-β-lactams: (a) Weath-
erwax, A.; Abraham, C. J.; Lectka, T. Org. Lett. 2005, 7, 3461–3463.
(b) Townes, J. A.; Evans, M. A.; Queffelec, J.; Taylor, S. J.; Morken, J. P.
Org. Lett. 2002, 4, 2537–2540. (c) Tanaka, H.; Hai, A. K. M. A.;
Sadakane, M.; Okumoto, H.; Torii, S. J. Org. Chem. 1994, 59, 3040–
3046.
Org. Lett., Vol. 14, No. 7, 2012
1785